134 related articles for article (PubMed ID: 11955750)
1. Does escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?
Hermann RM; Pradier O; Lauritzen K; Ott M; Schmidberger H; Hess CF
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1360-6. PubMed ID: 11955750
[TBL] [Abstract][Full Text] [Related]
2. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque.
Salkola S; Heikkonen J; Eskelin S; Kivelä T
Retina; 2014 Oct; 34(10):2110-20. PubMed ID: 24978431
[TBL] [Abstract][Full Text] [Related]
3. 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years.
Lommatzsch PK; Kirsch IH
Doc Ophthalmol; 1988; 68(3-4):225-38. PubMed ID: 3402313
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
5. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
6. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
7. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
8. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
9. Results of ruthenium irradiation of uveal melanomas: the Dutch experience.
Tjho-Heslinga RE; Davelaar J; Kemme HM; de Vroome H; Oosterhuis JA; Bleeker JC; Leer JW
Radiother Oncol; 1999 Nov; 53(2):133-7. PubMed ID: 10665790
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
Bacin F; Rozan R; Donnarieix D; Dalens H
Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy of Choroidal Melanomas Less Than 10 mm in Largest Basal Diameter: Comparison of 10-mm and 15-mm Ruthenium Plaques.
Jouhi S; Heikkonen J; Reijonen V; Raivio V; Täll M; Kivelä TT
Ophthalmology; 2021 Jan; 128(1):140-151. PubMed ID: 32649948
[TBL] [Abstract][Full Text] [Related]
12. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
13. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
16. Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.
Filì M; Trocme E; Herrspiegel C; Seregard S; Stålhammar G
Br J Ophthalmol; 2021 Jan; 105(1):57-62. PubMed ID: 32430342
[TBL] [Abstract][Full Text] [Related]
17. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
18. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
Kleineidam M; Guthoff R
Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
[TBL] [Abstract][Full Text] [Related]
20. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
